Podcast Episodes
Back to SearchNEJM February 19 2026 Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
This clinical study evaluates the effectiveness of combining two targeted immunotherapies, teclistamab and daratumumab, to treat patients with multip…
7 months, 3 weeks ago
JAMA February 5 Tenecteplase for Acute Non–Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke
The OPTION trial investigated whether the clot-dissolving drug tenecteplase could improve recovery for stroke patients who arrived at the hospital be…
8 months ago
JAMA February 11 Coffee and Tea Intake, Dementia Risk, and Cognitive Function.
This extensive longitudinal study tracked over 130,000 individuals for more than four decades to determine how beverage choices influence brain healt…
8 months ago
JAMA February 11 Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
This study investigates whether a seven-day injectable dose of medication-assisted treatment in the emergency department is more effective than the s…
8 months ago
NEJM February 2026 Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents
This clinical study evaluated whether patients with atrial fibrillation who have lived with a drug-eluting stent for at least one year should take a …
8 months ago
NEJM February 2026 A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
This scientific report details a significant medical study on a new treatment for IgA nephropathy, a common and dangerous kidney disease driven by ab…
8 months ago
NEJM February 2026 Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial
monoclonal antibody designed to block a protein called APRIL that fuels the progression of IgA nephropathy. By neutralizing this key driver, the drug…
8 months ago
Lancet February 2026 Smartwatch-derived versus self-reported outcomes of physiological recovery after COVID-19, influenza, and group A streptococcus: a 2-year prospective cohort study
This research investigates the discrepancy between how patients feel and how their bodies actually function after an illness, using smartwatch datato…
8 months, 1 week ago
Lancet February 2026, Delirium and adverse clinical outcomes: a matched cohort study in the UK Biobank
This research study reveals that experiencing delirium during a hospital stay acts as a sentinel event, signaling a widespread and long-term multisys…
8 months, 1 week ago
NEJM February 5,2026 Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
This clinical study investigates whether a novel drug combination can improve outcomes for patients facing HER2-positive metastatic breast cancer who…
8 months, 1 week ago